Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesInventoryLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Retained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Unicycive Therapeutics (UNCY) Prepaid Assets (2020 - 2026)

Unicycive Therapeutics filings provide 4 years of Prepaid Assets readings, the most recent being $4.8 million for Q4 2024.

  • On a quarterly basis, Prepaid Assets rose 1680.0% to $4.8 million in Q4 2024 year-over-year; TTM through Dec 2024 was $4.8 million, a 1680.0% increase, with the full-year FY2024 number at $4.8 million, up 1680.0% from a year prior.
  • Prepaid Assets hit $4.8 million in Q4 2024 for Unicycive Therapeutics, up from $397000.0 in the prior quarter.
  • In the past five years, Prepaid Assets ranged from a high of $4.8 million in Q4 2024 to a low of $15000.0 in Q2 2024.
  • Median Prepaid Assets over the past 4 years was $1.9 million (2023), compared with a mean of $2.0 million.
  • The widest YoY moves for Prepaid Assets: up 1680.0% in 2024, down 99.52% in 2024.
  • Unicycive Therapeutics' Prepaid Assets stood at $1.8 million in 2021, then grew by 19.49% to $2.2 million in 2022, then plummeted by 87.67% to $270000.0 in 2023, then skyrocketed by 1680.0% to $4.8 million in 2024.
  • The last three reported values for Prepaid Assets were $4.8 million (Q4 2024), $397000.0 (Q3 2024), and $15000.0 (Q2 2024) per Business Quant data.